Author:
Kong Gwyneth,Chew Nicholas W. S.,Ng Cheng Han,Chin Yip Han,Lim Oliver Z. H.,Ambhore Anand,Ng Gavin,Kong William,Poh Kian-Keong,Foo Roger,Yip James,Yeo Tiong-Cheng,Low Adrian Fatt-Hoe,Lee Chi-Hang,Chan Mark Yan-Yee,Tan Huay-Cheem,Loh Poay-Huan
Abstract
BackgroundAn increasing proportion of patients with acute myocardial infarction (AMI) are presenting without standard modifiable risk factors (SMuRFs) of hypertension, hypercholesterolemia, diabetes, and smoking, but with an unexpectedly increased mortality. This study examined the SMuRF-less patients presenting with AMI in a multiethnic Asian population.MethodsWe recruited patients presenting with AMI from 2011 to 2021 and compared the prevalence, clinical characteristics, and outcomes of SMuRF-less and SMuRF patients. Multivariable analysis was used to compare the outcomes of 30-day cardiovascular mortality, all-cause mortality, readmission, cardiogenic shock, stroke, and heart failure. Kaplan–Meier curves were constructed for 30-day cardiovascular mortality, with stratification by ethnicity, gender and AMI type, and 10-year all-cause mortality.ResultsStandard modifiable risk factor-less patients, who made up 8.6% of 8,680 patients, were significantly younger with fewer comorbidities that include stroke and chronic kidney disease, but higher rates of ventricular arrhythmias and inotropic or invasive ventilation requirement. Multivariable analysis showed higher rates of cardiovascular mortality (HR 1.48, 95% CI: 1.09–1.86, p = 0.048), cardiogenic shock (RR: 1.31, 95% CI: 1.09–1.52, p = 0.015), and stroke (RR: 2.51, 95% CI: 1.67–3.34, p = 0.030) among SMuRF-less patients. A 30-day cardiovascular mortality was raised in the SMuRF-less group, with similar trends in men, patients with ST-segment elevation myocardial infarction (STEMI), and the three Asian ethnicities. All-cause mortality remains increased in the SMuRF-less group for up to 5 years.ConclusionThere is a significant proportion of patients with AMI without standard risk factors in Asia, who have worse short-term mortality. This calls for greater focus on the management of this unexpectedly high-risk subgroup of patients.
Subject
Cardiology and Cardiovascular Medicine
Reference56 articles.
1. Definition of high risk individuals to optimise strategies for primary prevention of cardiovascular diseases;Giampaoli;Nutri Metabol Cardiovascul Dis.,2005
2. Serum total cholesterol and long-term coronary heart disease mortality in different cultures: twenty-five—year follow-up of the seven countries study;Verschuren;JAMA.,1995
3. Blood pressure, stroke, and coronary heart disease: part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias;MacMahon;The Lancet.,1990
4. The Health Benefits of Smoking Cessation: a report of the surgeon general dhhs publication no.(cdc) 90-8416,1990
5. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial;Stamler;Diabetes Care.,1993